1 hour ago
Amgen (AMGN) Stock Surges 4% on Breakthrough Sjögren’s Disease Trial Results
Amgen (AMGN) stock rose 4% after dazodalibep met Phase 3 trial goals for Sjögren's disease, with no FDA-approved competitors currently available.
The post Amgen (AMGN) Stock Surges 4% on Breakthrough Sjögren’s Disease Trial Results appeared first on Blockonomi.
Source: Blockonomi →Related News
- 16 minutes ago
SpaceX (SPCX) Stock: Advances as Merger Speculation Drives Attention
- 43 minutes ago
NVIDIA (NVDA) Stock: Gains as Apple Challenges Cloud AI With New Macs
- 51 minutes ago
Bitcoin (BTC) Surges Past $85K While Tech Stocks Drive Nasdaq to All-Time Highs
- 1 hour ago
PayPal (PYPL) Stock Surges 5% Following Meta’s Muse AI Integration Announcement
- 1 hour ago
UN Security Council Convenes AI Safety Meeting with OpenAI, DeepSeek, and Anthro...